NHS has SURPLUS of £2billion in the bank after underspending
By JO MACFARLANE
Last updated at 2:21 AM on 08th June 2008
Surplus: Shadow Health Secretary Andrew Lansley claimed the government had failed to use taxpayers money to provide care at a time of cuts
The NHS has underspent by more than £2billion after slashing training and cutting patient care.
About two per cent of last year's total NHS budget was not spent - just two years after the NHS was £547million in debt.
Meanwhile biotech in Britain in dying....thanks to NICE
In 2007, Sir David Cooksey, one of the fathers of British biotech said that "The UK is home to the strongest medical research community in Europe, yet there is no framework for bringing innovation from university laboratories and research organisations into the business world. The presence of the drugs-rationing group the National Institute of Health and Clinical Excellence adds a layer of bureaucracy absent in Europe or the United States."
Now...
Read Here
Peter Orzsag, the CBO Director who believes innovation is the source of many of the health care systems dysfunctions should be happy. Rationing innovation saves money...kills innovation. I am sure the perpetual priapism of self pronouncement against medical progress such as Merrill Goozner and Healthcare Renewal should be covulsing with joy over the demise of innovation and the surplus of dollars due to the denial of care as the result of comparative effectiveness. Dollars in the counting house from rationing. If only Dickens were alive today!
By JO MACFARLANE
Last updated at 2:21 AM on 08th June 2008
Surplus: Shadow Health Secretary Andrew Lansley claimed the government had failed to use taxpayers money to provide care at a time of cuts
The NHS has underspent by more than £2billion after slashing training and cutting patient care.
About two per cent of last year's total NHS budget was not spent - just two years after the NHS was £547million in debt.
Meanwhile biotech in Britain in dying....thanks to NICE
In 2007, Sir David Cooksey, one of the fathers of British biotech said that "The UK is home to the strongest medical research community in Europe, yet there is no framework for bringing innovation from university laboratories and research organisations into the business world. The presence of the drugs-rationing group the National Institute of Health and Clinical Excellence adds a layer of bureaucracy absent in Europe or the United States."
Now...
Read Here
UK biotech leaders demand government investment for its survival
Monday 8 December 2008
Simon Varcoe - Reporter
Peter Orzsag, the CBO Director who believes innovation is the source of many of the health care systems dysfunctions should be happy. Rationing innovation saves money...kills innovation. I am sure the perpetual priapism of self pronouncement against medical progress such as Merrill Goozner and Healthcare Renewal should be covulsing with joy over the demise of innovation and the surplus of dollars due to the denial of care as the result of comparative effectiveness. Dollars in the counting house from rationing. If only Dickens were alive today!
